On 10 September 2020, the Australian Competition and Consumer Commission (ACCC) announced it had accepted an undertaking (the Mylan/Upjohn Undertaking) given by Mylan N.V. and its subsidiary Alphapharm Pty Ltd and Upjohn Inc. and its subsidiary Upjohn Australia Pty Ltd pursuant to s 87B of the Competition and Consumer Act 2010 (Cth) in connection with Mylan N.V’s proposed combination with a new entity (Viatris) comprised of Pfizer’s Upjohn Inc. division, including Greenstone LLC (the Proposed Transaction). To support the Mylan/Upjohn Undertaking, the ACCC announced it had also accepted an undertaking given by Pfizer Inc. and Pfizer Australia Pty Ltd pursuant to s 87B of the Competition and Consumer Act 2010 (Cth) in connection with the Proposed Transaction.
The Australian Competition and Consumer Commission (ACCC) has accepted a court enforceable undertaking from Chrisco Hampers Australia Limited (Chrisco) in relation to sections 18, 23, 24, and 29(1)(d) of the Australian Consumer Law.
The Australian Competition and Consumer Commission (ACCC) has accepted a court enforceable undertaking from Medibank Private Limited (Medibank) in relation to contraventions of sections 18 and 29(1)(m) of the Australian Consumer Law.
The Australian Competition and Consumer Commission (ACCC) has accepted a court enforceable undertaking from Himanshu Bist, Director of Get Gizmo Pty Ltd (Get Gizmo), in relation to contraventions of the unsolicited consumer agreement provisions of the Australian Consumer Law.
On 9 July 2020, the ACCC announced it had accepted an undertaking (the Undertaking) from Elanco Animal Health Incorporated and its subsidiary Elanco Australasia Pty Ltd pursuant to s 87B of the Competition and Consumer Act 2010 (Cth) in connection with Elanco Animal Health Incorporated’s proposal to acquire Bayer AG’s animal health business (the Proposed Acquisition).
